Active Ingredient: TELBIVUDINE
Proprietary Name: TYZEKA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 600MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N022011
Product Number: 001
Approval Date: Oct 25, 2006
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:
Discontinued
Patent and Exclusivity Information
